1/178
exam 1, lecture 24
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
Where do the preganglionic neurons of the parasympathetic nervous system originate?
Craniosacral region
Where are most parasympathetic ganglia located?
Near or within the target effector
Does the parasympathetic nervous system have high or low divergence?
Low divergence
What is the approximate ratio of preganglionic to postganglionic fibers in the parasympathetic nervous system?
3:1
Why are parasympathetic effects more discrete and localized than sympathetic effects?
There is little divergence
What neurotransmitter is released by ALL autonomic preganglionic neurons?
Acetylcholine (ACh)
Nicotinic cholinergic receptors
Acetylcholine (ACh)
Muscarinic receptors
Recovering/restoring energy
Constriction (miosis)
Muscarinic receptor
Increases/stimulates GI activity
Bronchoconstriction
Muscarinic receptor
Decreases heart rate → bradycardia
Decreases blood pressure
Increases insulin release
Blood glucose decreases
Nicotinic and muscarinic
Acetylcholine
Autonomic ganglia
Ligand-gated ion channel
Na+
↑ Na+ permeability → depolarization → excitation
NM (muscular) and NN (neuronal)
Neuromuscular junction
Depolarization → skeletal muscle contraction
Autonomic ganglia
M1
M2 and M4
inhibits adenylyl cyclase
Receptor-operated K+ channels
M3
Non-innervated
Nitric oxide (NO)
Activation of guanylyl cyclase → vasodilation
Quaternary amine
Directly acting cholinergic agonists
Rapid fall in blood pressure of brief duration
Endothelial nitric oxide release → vasodilation
Decreases heart rate
Decreases speed of conduction
Increases both
Increases bladder contraction
Increases contraction
Causes constriction
Increases secretion
Miosis
Decreases intraocular pressure
No
Increases epinephrine and norepinephrine release
Depolarization and contraction
Parasympathomimetics
Acetylcholine-like effects on effector cells
Direct-acting and indirect-acting
Directly activate cholinergic receptors on effector cells
Cause ACh to accumulate in the synaptic junction → increased cholinergic action
Cholinesterase inhibitors / anticholinesterases
Bethanechol and pilocarpine
Choline ester/direct-acting parasympathomimetic
Natural alkaloid/direct-acting parasympathomimetic
Postsynaptic cholinergic receptors of target cells innervated by cholinergic nerves
Muscarinic receptors
No
Long acting
GI paralytic ileus and urinary retention associated with bladder muscle atony
Increases GI contractions/motility
Increases bladder contraction
it stimulates muscarinic receptors → increases bladder contraction
When there is a mechanical obstruction
Bethanechol
Bethanechol
Muscarinic receptors
M3
Causes contraction
Causes contraction → iris sphincter constriction/miosis
Increases outflow through the trabecular meshwork
Chronic and acute glaucoma
Increases tear production
Pilocarpine
Pilocarpine
Bronchoconstriction
Bronchoconstriction
Bradycardia
Miosis
Vomiting and diarrhea
Urinary incontinence
They can cause uterine contraction → abortion
Physostigmine
Organophosphate/DFP (diisopropyl fluorophosphate)
Inhibit AChE → ACh accumulation → increased cholinergic activity
Interact with AChE at the esteratic site
A stable enzyme-inhibitor complex forms through phosphorylation of the esteratic site
Recovery requires de novo synthesis of new enzyme
Reversibly combine with AChE → inhibit ACh hydrolysis → prolong ACh action
The reactivated enzyme hydrolyzes ACh
Glaucoma
Myasthenia gravis
Reversal of neuromuscular blockade